Overview
ABUS market data
Price History
ABUS price chart · 1M
- O
- 5.13
- H
- 5.14
- L
- 5.10
- C
- 5.12
- Vol
- 375,972.00
- Source
- US equities market feed
- Observed
- Sep 3, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $5.13
- Previous Close
- $5.09
- Day High
- $5.14
- Day Low
- $5.10
- 52 Week High
- $5.45
- 52 Week Low
- $4.07
- 7 Day Return
- -0.87%
- 30 Day Return
- +15.72%
- 90 Day Return
- +20.64%
- 1 Year Return
- +17.72%
- Daily Notional Volume
- $1.9M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 5.61 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.17 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.81 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 84.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $3.50 – $5.45 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $901.8M · P/B 12.08 · P/S 4.71.
Company News
9 captured
Arbutus Biopharma Announces Modified Dutch Auction Tender Offer To Purchase Up To $230M Of Common Shares At $5.00 To $5.75/Share, Expiring September 29Benzinga · Aug 24, 2026, 1:28 PM
Why Is Arbutus Biopharma Stock Gaining Friday?Benzinga · Aug 21, 2026, 4:36 PM
Arbutus Biopharma shares are trading higher after the company announced plans to commence a modified Dutch Auction tender offer to repurchase up to $230 million shares at no less than $5.00 per share and not more than $5.75 per share.Benzinga · Aug 21, 2026, 12:36 PM
Arbutus Biopharma Plans To Commence Modified Dutch Auction Tender Offer To Repurchase Up To $230M Of Common Shares At Purchase Price Of Between $5.00 And $5.75 Per Share In CashBenzinga · Aug 21, 2026, 12:01 PM
8-K filing — Arbutus Biopharma Corp (ABUS)SEC EDGAR · Aug 21, 2026, 11:53 AM
Arbutus Biopharma Announces Plans For Up To $230M Modified Dutch Auction Tender Offer At $5.00 To $5.75/Share; Expects To Commence August 24, Expire September 29Benzinga · Aug 21, 2026, 11:31 AM
Arbutus Biopharma Q2 EPS $(0.03) Misses $(0.02) Estimate, Sales $1.014M Beat $700.000K EstimateBenzinga · Aug 12, 2026, 11:34 AM
Arbutus Biopharma shares are trading higher after the company announced the filing of three international lawsuits seeking to enforce patent protecting LNP technology against Pfizer, BioNTech and certain or other affiliates.Benzinga · Jul 16, 2026, 1:08 PM
Arbutus Biopharma Announces Filing Of Three International Lawsuits Seeking To Enforce Patents Protecting LNP Technology Against Pfizer, BioNTech And Certain Of Their AffiliatesBenzinga · Jul 16, 2026, 11:39 AM